Header Logo

Connection

Dusan Stefoski to Kaplan-Meier Estimate

Back to Details
This is a "connection" page, showing publications Dusan Stefoski has written about Kaplan-Meier Estimate.
Dusan Stefoski
Connection Strength
0.028
Kaplan-Meier Estimate
  1. Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial. Lancet Neurol. 2014 May; 13(5):472-81.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.